Novo Nordisk shares pop 10% on early-stage weight loss drug trial results

A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024.

Tom Little | Reuters

Shares of Novo Nordisk jumped Friday after the Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

The trial showed average weight reduction of 22% in obese and overweight patients after 36 weeks.

Shares were last up 9.5% at 11:02 a.m. London time.

This is a developing story. Please check back for updates.

Source

World

British fintech Revolut reports record annual profit as it gears up for U.S. push

March 24, 2026

British fintech Revolut on Tuesday reported a record annual pretax profit, as it ramps up plans to expand into the U.S. following its long-awaited granting of a full U.K. banking license earlier this month. Profit before tax rose 57% to £1.7 billion ($2.3 billion) in 2025, compared to £1.09 billion in 2024. Group revenue increased […]

World

European stocks mixed as Iran war uncertainty lingers

March 24, 2026

A bull statue and a bear statue stand outside the Frankfurt Stock Exchange on April 7, 2025 in Frankfurt, Germany. Florian Wiegand | Getty Images News | Getty Images Shares listed in Europe struggled to find direction on Tuesday, as uncertainty around a resolution to the Iran war weighed on sentiment. Shortly after the opening […]

White House to pay TotalEnergies billion to kill off East Coast wind farm projects

World

White House to pay TotalEnergies $1 billion to kill off East Coast wind farm projects

March 24, 2026

An aerial view of wind turbines at the Altamont Pass wind farm on January 13, 2026 in Livermore, California. Justin Sullivan | Getty Images The White House has agreed to pay TotalEnergies $1 billion to shelve East Coast wind farm projects that it condemned as “costly,” with the French energy giant’s investment set to be […]